Correlation Between Reliance Industries and Mereo BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reliance Industries and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reliance Industries and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reliance Industries Ltd and Mereo BioPharma Group, you can compare the effects of market volatilities on Reliance Industries and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reliance Industries with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reliance Industries and Mereo BioPharma.

Diversification Opportunities for Reliance Industries and Mereo BioPharma

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Reliance and Mereo is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Reliance Industries Ltd and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Reliance Industries is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reliance Industries Ltd are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Reliance Industries i.e., Reliance Industries and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Reliance Industries and Mereo BioPharma

Assuming the 90 days trading horizon Reliance Industries Ltd is expected to under-perform the Mereo BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Reliance Industries Ltd is 3.07 times less risky than Mereo BioPharma. The stock trades about -0.2 of its potential returns per unit of risk. The Mereo BioPharma Group is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  432.00  in Mereo BioPharma Group on September 14, 2024 and sell it today you would lose (65.00) from holding Mereo BioPharma Group or give up 15.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.46%
ValuesDaily Returns

Reliance Industries Ltd  vs.  Mereo BioPharma Group

 Performance 
       Timeline  
Reliance Industries 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Reliance Industries Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Reliance Industries and Mereo BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reliance Industries and Mereo BioPharma

The main advantage of trading using opposite Reliance Industries and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reliance Industries position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.
The idea behind Reliance Industries Ltd and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.